Sign in

hjhansford.bsky.social

@hjhansford.bsky.social
55 followers 80 following 29 posts
PostsRepliesMedia
Reposted by @hjhansford.bsky.social
Georgia Tomova @georgiatomova.bsky.social · 15/06/2026
In our next seminar, Harrison Hansford will talk about the key reporting components of the TARGET guidelines, how TARGET was developed, and what comes next to improve both the reporting and conduct of studies that (claim to) emulate a target trial. 👉🏼 Register here: ucl.zoom.us/meeting/regi...
Flyer advertising the next CIIG seminar on 6th July with Harrison Hansford
041
Reposted by @hjhansford.bsky.social
JAMA @jama.com · 15/06/2026
Low back pain is defined as pain located below the costal margin and above the inferior gluteal folds, with or without leg pain and is the leading cause of years lived with disability worldwide, affecting people of all ages. Learn more in this Review: ja.ma/3SbmHVN
JAMA Review on Low Back Pain, published June 15, 2026. Figure 1 illustrates lumbar spine anatomy with posterior, lateral, and superior views, labeling vertebrae, muscles, nerves, and disks. Section B details pathophysiology with diagrams of lumbar radiculopathy (compressed nerve root, sciatic nerve pain) and spinal stenosis (disk protrusion, enlarged facet joint).
093
hjhansford.bsky.social @hjhansford.bsky.social · 07/11/2025
Thrilled to see PLOS Medicine (@plos.org) now REQUIRES the TARGET checklist to be completed for submitted target trial emulations. doi.org/10.1371/journal.pmed.1004796 Transparent reporting shouldn't be optional, if you edit at a journal, please encourage your EiC or publishers to follow suit.
doi.org
Raising the bar for causal inference: PLOS Medicine adopts the TARGET guidelines for target trial emulation studies
The TARGET guidelines aim to improve transparency and consistency in reporting of observational studies that emulate target trials. This Editorial announces that PLOS Medicine fully endorses the TARGE...
0114
Reposted by @hjhansford.bsky.social
Council of Canadian Academies/Conseil des académies canadiennes @cca-reports.ca · 22/10/2025
🧠 Balancing open science with research security is a hallmark of the modern research mindset. Researchers can foster discovery and collaboration, while also safeguarding sensitive data and intellectual property from misuse. 🧪 Learn more ➡️ go.cca-reports.ca/3KPUnob
Social card with text describing attributes of the modern research mindset.
035
Reposted by @hjhansford.bsky.social
Brennan Kahan @brennankahan.bsky.social · 22/10/2025
New PhD position available at @mrcctu.bsky.social to develop guidance on balancing statistical and clinical considerations when choosing an estimand in RCTs. www.findaphd.com/phds/project...
findaphd.com
Optimising the choice of estimand in randomised trials: developing guidance on balancing statistical and clinical considerations to ensure results matter to stakeholders at University College London o...
PhD Project - Optimising the choice of estimand in randomised trials: developing guidance on balancing statistical and clinical considerations to ensure results matter to stakeholders at University Co...
0610
Reposted by @hjhansford.bsky.social
David Laursen @davidlaursen.bsky.social · 17/10/2025
Does unblinding due to side effects lead to bias in placebo-controlled trials? And are active placebos a possible solution? (Spoiler alert: we are not sure.) #ActivePlacebo #ActivePlacebos #Blinding #Unblinding #Placebo #Bias 1/10
Lady Justice partially removing her blindfold from one eye
493
Reposted by @hjhansford.bsky.social
Peter Tennant @pwgtennant.bsky.social · 16/10/2025
Roll up, roll up. Get your snake oil and miracle cures here! ✅ Precision medicine ✅ Automated causal inference ✅ Polygenic scores ✅ 1000+ outcome prediction models ✅ In sillico trials ✅ Exposomics ✅ Anything involve 'AI' ✅ Any other trend, shortcut, or bandwagon!
53810
hjhansford.bsky.social @hjhansford.bsky.social · 15/10/2025
As use of target trial emulation increases, transparent reporting is critical to allow readers to pick the good from the bad. We argue that TARGET will improve peer review, appraisal and trust in target trial emulations & journals should encourage its use. doi.org/10.1371/journal.pmed.1004787
doi.org
Improving reporting of observational studies of interventions: The TARGET guideline
In this Perspective, Harrison Hansford and colleagues outline how the TARGET guidelines can improve the reporting transparency of observational studies emulating a target trial and help readers apprai...
142
Reposted by @hjhansford.bsky.social
Tim Feeney @tfeend.bsky.social · 24/09/2025
Every. Single. Time. Although i think the falling off the bike is me *truly* learning the method.
051
Reposted by @hjhansford.bsky.social
Margarita Moreno-Betancur @margaritamb.bsky.social · 10/09/2025
NEW PAPER! (in press in EPIDEMIOLOGY) Have you wondered: - How to specify a target trial: as an ideal trial or something else? - What biases do target trial emulations and actual RCTs share? - How does it all relate to potential outcomes? Read here! 👉 arxiv.org/abs/2405.10026 #EpiSky #CausalSky
arxiv.org
The ideal trial: defining causal estimands that balance relevance and feasibility in target trial emulations and actual randomized trials
Causal inference is the goal of randomized trials and many observational studies. The first step in a formal causal inference framework is to define the causal estimand, and in both types of study thi...
2258
Reposted by @hjhansford.bsky.social
Jack Wilkinson @jdwilko.bsky.social · 08/09/2025
For Monday crowd. INSPECT-SR, a tool to help you identify problematic (inc. fraudulent) RCTs, now available.
0179
Reposted by @hjhansford.bsky.social
Jack Wilkinson @jdwilko.bsky.social · 05/09/2025
A detailed guidance document and editable template are available here: osf.io/b74wj/files/...
osf.io
OSF
131
Reposted by @hjhansford.bsky.social
Jack Wilkinson @jdwilko.bsky.social · 05/09/2025
www.medrxiv.org/content/10.1... INSPECT-SR: A tool for assessing trustworthiness of randomised controlled trials.
medrxiv.org
INSPECT-SR: a tool for assessing trustworthiness of randomised controlled trials
The integrity of evidence synthesis is threatened by problematic randomised controlled trials (RCTs). These are RCTs where there are serious concerns about the trustworthiness of the data or findings....
37137
Reposted by @hjhansford.bsky.social
hjhansford.bsky.social @hjhansford.bsky.social · 03/09/2025
🎯 TARGET Guideline published 🎉 TARGET is a reporting guideline for observational studies of interventions that use the target trial framework. Over 3 years the @TARGETGuideline was rigorously developed and was co-published today in @jama.com & @bmj.com doi.org/10.1001/jama.2025.13350 #episky
31411
Reposted by @hjhansford.bsky.social
Darren Dahly @statsepi.bsky.social · 05/09/2025
One of the most common misunderstandings about the use and value of placebos in clinical RCTs, often made by both methodological experts and experienced trialists: (from @stephensenn.bsky.social in academic.oup.com/jrsssa/advan...)
A further problem is illustrated by the authors equating no treatment with placebo. For example, describing their second assumption, they state, ‘Implicit in this notation is that there is a single version of ‘no treatment’ that is consistently defined across all subjects in the RCT and external controls’ (p4). However, most clinical trials are add-on trials (Senn, 2002), even if not specifically identified as such. In placebo-controlled trials, one starts with standard of care and then subjects are either allocated to receive in addition the active treatment or a placebo to it. The statistical analysis plan for SUNFISH (F Hoffman-La-Roche Ltd, 2020) has a protocol summary as Appendix 1, which has this to say, ‘In addition to the study drug treatment, patients may continue to receive concomitant drug medication…’ (p186). This is very standard for clinical trials. It highlights that a key assumption in borrowing control data in this way is that there has been no evolution in the standard of care in the period since the trial.
34514
Reposted by @hjhansford.bsky.social
Peer Review Congress #PRC11 Coming 2029! @peerreviewcongress.bsky.social · 04/09/2025
In the med literature, statements like “to our knowledge [TOK], this is the FIRST...” often replace a proper systematic search. Among 4488 PMC articles in 6 leading medical journals published 2020-2024, TOK prevalence was 21.7%, w @PLOSMedicine highest (48.4%) and @NEJM lowest (1.3%) #CornellVet
In 2 journals, Journal of Small Animal Practice (JSAP) and Journal of Exotic Pet Medicine (JEPM), an intervention to advise authors against use of these phrases and in favor of a scoping search of the literature was implemented in 2020, w decreases from 37.4% to 7.6% after the intervention.
173
Reposted by @hjhansford.bsky.social
Tim Feeney @tfeend.bsky.social · 03/09/2025
Out this morning, TARGET a guideline to help get target trial emulation studies to report a standard set of items #prc10 @peerreviewcongress.bsky.social @bmj.com @societyforepi.bsky.social
2113
Reposted by @hjhansford.bsky.social
Miguel Hernan @miguelhernan.org · 03/09/2025
When using observational data for #causalinference, the choice isn’t between emulating or not emulating a #TargetTrial, but between reporting or not reporting the target trial that we are emulating. For those who prefer to be explicit about what they do, we have developed the TARGET Statement 👇
1237
hjhansford.bsky.social @hjhansford.bsky.social · 03/09/2025
🎯 TARGET Guideline published 🎉 TARGET is a reporting guideline for observational studies of interventions that use the target trial framework. Over 3 years the @TARGETGuideline was rigorously developed and was co-published today in @jama.com & @bmj.com doi.org/10.1001/jama.2025.13350 #episky
31411
Reposted by @hjhansford.bsky.social
Rebecca Sear @rebeccasear.bsky.social · 21/08/2025
OSF is reviewing its generalist preprint server partly because of “Volume and quality challenges: The generalist server has seen increasing numbers of suspicious or low-quality submissions…trends such as generative AI and paper mills have introduced new risks to research integrity”
cos.io
Suspension of Submissions to Generalist Preprint Server for Review and Next Steps — Community Servers Hosted by OSF Preprints Remain Active
Effective August 25, 2025, COS will suspend submissions to its generalist preprint server hosted by OSF Preprints. The generalist server has operated alongside community-run preprint servers on OSF Pr...
078
Reposted by @hjhansford.bsky.social
Darren Dahly @statsepi.bsky.social · 26/08/2025
There's no reason not to share data from a systematic literature review, other than cowardice.
No data are available. The data explored in this systematic review and meta-analysis have been extracted from publicly available databases. Although the authors will not share the data directly, any interested researcher may apply the search strategy developed for this analysis, available in the online supplemental appendix.
87219
Reposted by @hjhansford.bsky.social
Myra McGuinness @myramcguinness.bsky.social · 11/08/2025
September @vicbiostat.bsky.social seminar: Camila Olarte Parra from @causalab.bsky.social Karolinska will speak on combining information from trial participants and non-participants in registry-based trials. All welcome online 25 September. More info: www.vicbiostat.org.au/event/combin...
vicbiostat.org.au
Combining information from trial participants and non-participants in registry-based trials
Even though the advantages of randomised tria
063
Reposted by @hjhansford.bsky.social
Michael Ferraro @mcferraro.bsky.social · 18/08/2025
Out today 🚨 Our Cochrane review of 67 RCTs finds no clear evidence of benefit for ketamine or other NMDA antagonists for chronic pain. IV ketamine associated with risk of psychotomimetic effects, nausea, and vomiting. doi.org/10.1002/1465...
doi.org
Ketamine and other NMDA receptor antagonists for chronic pain - Ferraro, MC - 2025 | Cochrane Library
Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.
123
Reposted by @hjhansford.bsky.social
JAMA @jama.com · 10/08/2025
📌 The SPIRIT 2025 statement updates the guidelines for randomized trial protocols to enhance their completeness, transparency, and consistency, benefiting stakeholders involved in clinical research. ja.ma/4fzMVZS
Figure.  SPIRIT 2025 Diagram of the Schedule of Enrollment, Interventions, and Assessments
03020
Reposted by @hjhansford.bsky.social
Dan Quintana @dsquintana.bsky.social · 13/08/2025
Systematic reviewers have a 10.7% error rate when screening papers for potential inclusion. In other words, about 1 in 9 abstracts are categorised incorrectly (i.e., false inclusion or false exclusion). This really drives home the benefit of having at least two screeners
doi.org
Error rates of human reviewers during abstract screening in systematic reviews
Background Automated approaches to improve the efficiency of systematic reviews are greatly needed. When testing any of these approaches, the criterion standard of comparison (gold standard) is usuall...
27728
Reposted by @hjhansford.bsky.social
Hannah Ritchie @hannahritchie.bsky.social · 13/08/2025
This decline is not limited to the United States. It has been happening in many countries.
2476
Reposted by @hjhansford.bsky.social
Hannah Ritchie @hannahritchie.bsky.social · 13/08/2025
Death rates from cardiovascular disease have been falling for a long time, but we rarely hear about it. @scientificdiscovery.dev looks at some of the medical innovations and changes in risk factors that are behind this: ourworldindata.org/cardiovascul...
516533
Reposted by @hjhansford.bsky.social
Darren Dahly @statsepi.bsky.social · 12/08/2025
A letter from myself and @jdwilko.bsky.social that expands on this a bit more. Thanks to Fertility and Sterility for the opportunity. doi.org/10.1016/j.fe...
Nonrandomized studies of
interventions - complementary or
just convenient?
Schwarze et al. (1) present recommendations to improve the
quality of nonrandomized studies of interventions (NRSIs).
Given the methodological errors we regularly encounter
when reading and reviewing NRSIs in assisted reproductive
technologies (ART), we support the need for such
recommendations to help researchers better design,
analyze, and interpret these studies. That said, we are
concerned that those who require such guidance will,
almost by definition, not understand when the use of
NRSIs is warranted, or mistake them as viable alternatives
to randomized controlled trials (RCTs), despite reassurances
from Schwarze et al. (1) that NRSIs should be viewed as
complementary. Our concerns are particularly relevant for
ART, where regulation is limited, commercial conflicts of
interest are common, and interventions are regularly
adopted before they are evaluated using RCTs. To be clear,
we do not see these as points of disagreement with
Schwarze et al. (1), but rather as additional points for
consideration.
25526
Reposted by @hjhansford.bsky.social
AusRN @ausrepro.bsky.social · 06/08/2025
Care about #reproducibility in research & publishing? Join this webinar on Aug 27th, jointly organised by @aimosinc.bsky.social & @ausrepro.bsky.social on statistical reproducibility with @michelenuijten.bsky.social & @tomhardwicke.bsky.social Free - register here qut.zoom.us/meeting/regi...
01514
hjhansford.bsky.social @hjhansford.bsky.social · 07/08/2025
Super exciting to see this published by Susie! This started as a 4th year lit review and became a really constructive piece in the BJSM! Whilst a big step forward, perhaps the IOC statement on RED-S overlooks the coaches role? doi.org/10.1136/bjsports-2024-109563
000
Reposted by @hjhansford.bsky.social
Peter Tennant @pwgtennant.bsky.social · 17/07/2025
Once you truly understand causal inference theory, it's very hard to win an honest applied grant because: * Many questions can't be answered * Almost everything that sounds big and exciting is snake oil * Most reviewers won't understand * you're competing with the bandwagon-jumping cynics
4697
hjhansford.bsky.social @hjhansford.bsky.social · 17/07/2025
One-Page Patient Fact Sheets for Low Back Pain in Primary Care Fact sheets do better than regular advice to support shared decision making! jamanetwork.com/journals/jam...
jamanetwork.com
One-Page Patient Fact Sheets for Low Back Pain in Primary Care
This randomized clinical trial compares the effects of 1-page fact sheets that adopt either an information-listing approach or a direct advice approach on management of low back pain to prepare patien...
011
hjhansford.bsky.social @hjhansford.bsky.social · 17/07/2025
Great opening plenary by Prof Matt Fox about the role of intuition in epidemiology - some key takeaways were that intuition can be helpful, but also detrimental. Quantifying uncertainty can be a good strategy to avoid making readers (and yourself) not have to use intuition! #AEA2025
011
Reposted by @hjhansford.bsky.social
ANZMUSC @anzmusc.bsky.social · 01/07/2025
Congrats to the ANZMUSC members who presented their research at the 19th IBNP Forum last week in Switzerland!🇨🇭 Fantastic to see strong Australian involvement - 69 participants from Aus and 1 from NZ - and to witness numerous sessions facilitated by these attendees.
022
Reposted by @hjhansford.bsky.social
Karen Davis @karenddavis.bsky.social · 08/07/2025
Editorial commitment to trust and integrity in science: implications for pain and anesthesiology research journals.lww.com/pain/fulltex...
journals.lww.com
Editorial commitment to trust and integrity in science:... : PAIN
An abstract is unavailable.
086
Reposted by @hjhansford.bsky.social
Brian Nosek @briannosek.bsky.social · 09/07/2025
The primary impact of openness is to make it possible to evaluate research for improvement and self-correction. Openness doesn’t solve quality challenges itself, except possibly a minor influence on accountability because others look, or could look.
0184
Reposted by @hjhansford.bsky.social
Richard McElreath 🐈‍⬛ @rmcelreath.bsky.social · 09/07/2025
How can we reform science? I have some ideas. But I am not sure you’ll like them, because they don’t promise much. elevanth.org/blog/2025/07...
elevanth.org
Which Kind of Science Reform
What hope is there for science reform, if we can't agree on what to reform? Right now, principles are more important than practices.
15284136
Reposted by @hjhansford.bsky.social
Jack Wilkinson @jdwilko.bsky.social · 11/06/2025
Concerns raised about an RCT of Vitamin K2 in JAMA Internal Medicine: www.pubpeer.com/publications...
pubpeer.com
PubPeer - Vitamin K2 in Managing Nocturnal Leg Cramps: A Randomized Cl...
There are comments on PubPeer for publication: Vitamin K2 in Managing Nocturnal Leg Cramps: A Randomized Clinical Trial (2024)
133
Reposted by @hjhansford.bsky.social
Mark A. Hanson @hansonmark.bsky.social · 10/06/2025
New from The Strain Team: 🎊 Springer Nature Discovers MDPI 🎊 Springer Nature has spawned a copycat journal series called "Discover" mimicking #MDPI journal titles and citation behaviours. We even made a browser game to prove it (see 🔗). Gross! 😀 1/n #ResearchIntegrity #SciPub #AcademicSky
the-strain-on-scientific-publishing.github.io
Spinger Nature Discovers MDPI – The Strain on Scientific Publishing
Home page for the paper ‘The Strain on Scientific Publishing’ by Mark A Hanson, Dan Brockington, Paolo Crosetto and Pablo Gomez Barreiro
12248184
Reposted by @hjhansford.bsky.social
Jennifer Byrne @jabyrnesci.bsky.social · 15/05/2025
International #ResearchIntegrity conference taking place in beautiful Sydney Australia on 16-18 November 2025 🐨 🌏 Great speakers including @elisabethbik.bsky.social @jdwilko.bsky.social @jasonchin.bsky.social For more info contact @simongandevia.bsky.social 🧪
12514
Reposted by @hjhansford.bsky.social
Our World in Data @ourworldindata.org · 15/05/2025
What do governments spend money on?
A stacked bar chart showing the share of total government spending by category for a selection of OECD countries. The data is from 2022, the latest year available.

The countries are Finland, Germany, Japan, Sweden, Greece, the UK, Chile, Australia, South Korea, and the US.

The categories are Social protection, Health, Education, Economic affairs, Public services, Other (which includes public safety, environment, housing, and recreation/culture), and Defense.

For some categories, such as public services, the share spent is fairly similar across countries: it ranges from a low of 9% in Japan to a high of 15% in the US and Finland.

In other categories, such as social protection, the difference across countries is much larger: from a low of 21% in the US to a high of 44% in Finland.
59233
Reposted by @hjhansford.bsky.social
Elizabeth Stuart @lizstuart.bsky.social · 07/05/2025
Great way to learn the basics of policy trial emulation and the importance of careful study design for health policy!
061
Reposted by @hjhansford.bsky.social
Ghazaleh Dashti @ghazalehd.bsky.social · 02/05/2025
📢 New Commentary: We discuss how analytic choices impact interpretation of studies on socioeconomic health inequities. We review 1) descriptive analogues of causal estimands (à la Young et al) with competing events; 2) timescale choice; and 3) covariate adjustment. 👉 academic.oup.com/aje/advance-...
academic.oup.com
Invited commentary: Descriptive social epidemiology: putting the question before the methods
Abstract. In studies describing socioeconomic inequities in health outcomes, the choice of estimand and the planned analytic approach are central to the in
1137
Reposted by @hjhansford.bsky.social
Peter Tennant @pwgtennant.bsky.social · 29/04/2025
No. This study does not show that drinking champagne could reduce your risk of cardiac arrest. It shows that many things can predict your chances of cardiac arrest. Unsurprisingly, this includes the amount of champagne you drink, which is doubtless a marker of wealth.
1015624
Reposted by @hjhansford.bsky.social
Gary Collins @gscollins.bsky.social · 29/04/2025
NEW PAPER: Updated SPIRIT-2025 for reporting protocols of randomised trials is now available in the @BMJ.com, @JAMA.com, @thelancet.bsky.social, @PLoS.org, and @natmedicine.bsky.social. —> www.bmj.com/content/389/... #openscience #transparency #medsky #statssky #episky
12622
Reposted by @hjhansford.bsky.social
Brennan Kahan @brennankahan.bsky.social · 29/04/2025
SPIRIT 2025 guidelines for protocols now published in @bmj.com journal and others www.bmj.com/content/389/...
bmj.com
SPIRIT 2025 statement: updated guideline for protocols of randomised trials
Importance The protocol of a randomised trial is the foundation for study planning, conduct, reporting, and external review. However, trial protocols vary in their completeness and often do not addres...
222
Reposted by @hjhansford.bsky.social
aamri.bsky.social @aamri.bsky.social · 15/04/2025
We can't work out why funds designated to medical research can't be released from the MRFF. So we animated it 👇. Share this & help AAMRI secure the election promise that these unspent funds, that are allocated and available, will be released. #standupforscience2025 #election2025
1103
Reposted by @hjhansford.bsky.social
The BMJ @bmj.com · 17/04/2025
The CONSORT statement has been updated to reflect recent methodological advancements and user feedback. This article describes the rationale for each checklist item and provides published examples of good reporting www.bmj.com/content/389/...
A person looking at data
02611
hjhansford.bsky.social @hjhansford.bsky.social · 15/04/2025
Awesome talk from rising star Mia Ryan on GP and people with low back pain perspectives of mobile health apps for the management of pain. High quality, trustworthy apps are needed. Thankfully the team at the Centre for Pain IMPACT is doing a clinical trial of such an app! #AusPainSoc
000